News
The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback